慢性阻塞性肺病 (COPD) 的护理途径与常规护理
Mahtab Pajand Birjandi1, Omar Ammous2, Regina Kampo2
1Faculty of medicine, Georg-August-University, Göttingen, Germany.
The Cochrane database of systematic reviews
|August 14, 2024
概括
护理途径 (CPs) 可以改善慢性阻塞性肺病 (COPD) 患者的治疗结果. 这次审查将将CP与常规护理进行比较,以评估它们对COPD管理和患者健康的影响.
科学领域:
- 肺部病理学 肺部病理学
- 医疗保健管理的管理
- 临床干预 临床干预
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种具有重大全球健康影响的渐进性呼吸道疾病.
- 有效的管理策略对于改善患者的治疗结果和减少医疗保健负担至关重要.
- 护理途径 (CPs) 为患者管理提供了一个结构化的方法,有可能优化治疗交付.
研究的目的:
- 系统地评估护理途径 (CPs) 与常规护理对被诊断患有慢性阻塞性肺病 (COPD) 的人的影响.
- 综合证据证明CP在治疗COPD患者中的有效性.
主要方法:
- 本议定书概述了柯克伦审查,这是一个严格的系统审查方法.
- 审查将将涉及护理途径 (CP) 的干预措施与常规护理或没有CP进行比较.
- 重点是评估这些不同的COPD管理方法的影响.
主要成果:
- 结果正在等待系统审查和数据综合的完成.
- 审查旨在确定两种管理策略之间结果的任何显著差异.
- 将介绍关于慢性慢性病的CP的疗效的证据.
结论:
- 这些发现将为临床实践和医疗保健政策提供COPD管理方面的信息.
- 这一审查将提供基于证据的建议,关于使用COPD患者的CP.
- 了解CP的比较有效性对于优化患者护理和资源配置至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.7K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190


